论文信息 - Discovery of the Oral Leukotriene-C4 Synthetase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid (AZD9898) as a New Treatment for Asthma. - 字舞流文

Discovery of the Oral Leukotriene-C4 Synthetase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid (AZD9898) as a New Treatment for Asthma.

L. Swedin | U. Andersson | C. Tyrchan | Hui-Fang Chang | A. Lundqvist | H. Käck | Anna Pettersen | F. Wågberg | B. Bonn | M. Rohman | E. Björkstrand | T. Andreasson | P. Johannesson | P. Glader | L. Ripa | E. Gordon | Andrew M Davis | D. Chapman | Magnus Munck af Rosenschöld | Xiao-hong Zhou | A. Malmberg | V. Ullah | G. Nikitidis | M. Ek | Robert Rönn | A. Nikitidis | Fanyi Jiang | E. L. Bergström